GridAI Technologies (GRDX) Preferred Stock Liabilities (2024 - 2026)
GridAI Technologies' (GRDX) quarterly Preferred Stock Liabilities came in at $3.9 million in Q2 2026, down 93.68% on a YoY basis from $61.7 million in Q2 2025, and little changed quarter-over-quarter from $3.9 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) Preferred Stock Liabilities (2024 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Preferred Stock Liabilities for 3 consecutive years, with $3.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Preferred Stock Liabilities fell 93.68% year-over-year to $3.9 million; the trailing twelve-month figure through Jun 2026 stood at $3.9 million (down 93.68% YoY), and the FY2025 full-year result was $3.9 million, down 93.68% from the prior year.
- Preferred Stock Liabilities held at $3.9 million in Q2 2026 per GRDX's latest filing, from $3.9 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $61.7 million in Q1 2024 and bottomed at $3.9 million in Q4 2025.
- Historically, Preferred Stock Liabilities has averaged $48.8 million across 3 years, with a median of $61.7 million in 2024.
- The widest YoY moves for Preferred Stock Liabilities: up 0.0% in 2025, down 93.68% in 2025.
- Over 3 years, Preferred Stock Liabilities stood at $61.7 million in 2024, then tumbled by 93.68% to $3.9 million in 2025, then changed by 0.0% to $3.9 million in 2026.
- According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $3.9 million, $3.9 million, and $61.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | 3.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.90 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 61.68 Mn |
| Jun 30, 2025 | 61.68 Mn |
| Mar 31, 2025 | 61.68 Mn |
| Dec 31, 2024 | 61.68 Mn |
| Sep 30, 2024 | 61.68 Mn |
| Jun 30, 2024 | 61.68 Mn |
| Mar 31, 2024 | 61.68 Mn |